<p>Panel A: Box-plot showing the differences in the median (horizontal lines), interquartile range (boxes) and 95% of the observed values (whiskers) for sACE2 activity between controls and STEMI patients. Panel B: Scatter-plot detailing individual changes in sACE2 activity among patients. *: p<0.001 for comparison between baseline measurements in patients and controls. †: p<0.01 for comparison between baseline and 7 days measurements by paired analysis. ACE2: Angiotensin Converting Enzyme 2; RFU: relative fluorometric units.</p
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotecti...
<p>The Y axes show the standardized differences in lipid level: lipid levels were standardized to a ...
Objective: Angiotensin-converting enzyme and its effector peptide angiotensin II have been implicate...
<p>Data expressed as relative fluorometric units per microliter per hour (RFU/µl/hr).</p>*<p>p<0.001...
<p>Scatter-plots showing a statistically significant correlation between ACE2 activity at 7 days and...
<p>A weak but significant correlation was observed between infarct size and sACE2 activity at 7 days...
<p>(A) Graph depicts box plots of urinary ACE2 activity in control subjects (n = 50) and Tx recipien...
<p>Serum ACE2 activity levels were determined in healthy people (healthy, n = 45, filled bar, panel ...
<p>SME 1 (Peptide NSEPQDEGELFQGVDPR, from neurosecretory protein VGF precursor) and SME2 (peptide VA...
Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in defini...
<p>Circulating Angpt-2 in septic patients (n = 8) (A), patients with need of intensive care treatmen...
<div><p>Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1–7), a cardio...
Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in defini...
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotecti...
<p>The table shows the summary statistics for three biomarkers in the ACS patients and controls. For...
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotecti...
<p>The Y axes show the standardized differences in lipid level: lipid levels were standardized to a ...
Objective: Angiotensin-converting enzyme and its effector peptide angiotensin II have been implicate...
<p>Data expressed as relative fluorometric units per microliter per hour (RFU/µl/hr).</p>*<p>p<0.001...
<p>Scatter-plots showing a statistically significant correlation between ACE2 activity at 7 days and...
<p>A weak but significant correlation was observed between infarct size and sACE2 activity at 7 days...
<p>(A) Graph depicts box plots of urinary ACE2 activity in control subjects (n = 50) and Tx recipien...
<p>Serum ACE2 activity levels were determined in healthy people (healthy, n = 45, filled bar, panel ...
<p>SME 1 (Peptide NSEPQDEGELFQGVDPR, from neurosecretory protein VGF precursor) and SME2 (peptide VA...
Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in defini...
<p>Circulating Angpt-2 in septic patients (n = 8) (A), patients with need of intensive care treatmen...
<div><p>Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1–7), a cardio...
Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in defini...
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotecti...
<p>The table shows the summary statistics for three biomarkers in the ACS patients and controls. For...
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1-7), a cardioprotecti...
<p>The Y axes show the standardized differences in lipid level: lipid levels were standardized to a ...
Objective: Angiotensin-converting enzyme and its effector peptide angiotensin II have been implicate...